Vitamin D insufficiency and deficiency in children with early chronic kidney disease. 2009

Wacharee Seeherunvong, and Carolyn L Abitbol, and Jayanthi Chandar, and Gaston Zilleruelo, and Michael Freundlich
Department of Pediatrics, Division of Pediatric Nephrology and Holtz Children's Hospital, Miller School of Medicine, University of Miami, Miami, FL 33101, USA.

OBJECTIVE To assess the prevalence of abnormal vitamin D status in children and adolescents with chronic kidney disease (CKD). METHODS This was an outpatient cross-sectional, retrospective study of 258 patients, mean age 12.3 +/- 5.2 years, with an average estimated glomerular filtration rate (eGFR) of 106 +/- 51 mL/min/1.73 m2 (range, 0 to 220 mL/min/1.73 m2). Serum 25-hydroxy-vitamin D [25(OH)D], calcium, phosphorus, and parathyroid hormone levels, as well as selected anthropometric variables, were analyzed. RESULTS Reduced 25(OH)D concentrations (< 30 ng/mL) were found in 60% of the patients. In 28%, the concentration was < 20 ng/mL, indicating vitamin D deficiency. Patients with more advanced CKD were more likely to have vitamin D deficiency compared with those with incipient CKD or normal GFR (42% vs 26%; P = .03) and displayed more prominent hyperparathyroidism. Suboptimal vitamin D status was similar in males and females, but was significantly more prevalent in older (P < .01), non-Caucasian (P < .01), and overweight (P = .02) patients. Patients with early-stage CKD (eGFR > 60 mL/min/1.73 m2) and with vitamin D deficiency were significantly shorter than their counterparts with 25(OH)D levels > 20 ng/mL (P = .02). CONCLUSIONS Vitamin D insufficiency and deficiency are very prevalent in pediatric patients across all stages of CKD, particularly in non-Caucasian and obese patients, and may contribute to growth deficits during the earliest stages of CKD.

UI MeSH Term Description Entries
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010758 Phosphorus A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions. Black Phosphorus,Phosphorus-31,Red Phosphorus,White Phosphorus,Yellow Phosphorus,Phosphorus 31,Phosphorus, Black,Phosphorus, Red,Phosphorus, White,Phosphorus, Yellow
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005431 Florida State bounded on east by the Atlantic Ocean, on the south by the Gulf of Mexico, on the west by Alabama and on the north by Alabama and Georgia.

Related Publications

Wacharee Seeherunvong, and Carolyn L Abitbol, and Jayanthi Chandar, and Gaston Zilleruelo, and Michael Freundlich
January 2012, Annals of Saudi medicine,
Wacharee Seeherunvong, and Carolyn L Abitbol, and Jayanthi Chandar, and Gaston Zilleruelo, and Michael Freundlich
March 2012, Jornal brasileiro de nefrologia,
Wacharee Seeherunvong, and Carolyn L Abitbol, and Jayanthi Chandar, and Gaston Zilleruelo, and Michael Freundlich
October 2008, Pediatric nephrology (Berlin, Germany),
Wacharee Seeherunvong, and Carolyn L Abitbol, and Jayanthi Chandar, and Gaston Zilleruelo, and Michael Freundlich
November 2018, Pediatric nephrology (Berlin, Germany),
Wacharee Seeherunvong, and Carolyn L Abitbol, and Jayanthi Chandar, and Gaston Zilleruelo, and Michael Freundlich
April 2010, Kidney international,
Wacharee Seeherunvong, and Carolyn L Abitbol, and Jayanthi Chandar, and Gaston Zilleruelo, and Michael Freundlich
July 2012, Saudi medical journal,
Wacharee Seeherunvong, and Carolyn L Abitbol, and Jayanthi Chandar, and Gaston Zilleruelo, and Michael Freundlich
December 2010, Pediatric nephrology (Berlin, Germany),
Wacharee Seeherunvong, and Carolyn L Abitbol, and Jayanthi Chandar, and Gaston Zilleruelo, and Michael Freundlich
March 2009, Pediatrics,
Wacharee Seeherunvong, and Carolyn L Abitbol, and Jayanthi Chandar, and Gaston Zilleruelo, and Michael Freundlich
October 2013, BMC nephrology,
Wacharee Seeherunvong, and Carolyn L Abitbol, and Jayanthi Chandar, and Gaston Zilleruelo, and Michael Freundlich
April 2012, Kidney international,
Copied contents to your clipboard!